Clinical Trial Update: Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine [Phase 1]

View source ↗

Summary

Phase 1 study results update evaluating a booster dose of the GBS-NN/NN2 vaccine for Group B Streptococcus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Group Streptococcus Infection

Drugs mentioned

• GBS-NN/NN2 vaccine (GBS-NN/NN2 vaccine)

Snippet

Sponsor: Minervax ApS | Conditions: Group B Streptococcus Infection | Phase 1 | Status: COMPLETED | Results posted: 2024-10-10